Tais Hanae Kasai Brunswick

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Centro Nacional de Biologia Estrutural e Bioimagem

Departamento:

Gabinete da Direção/CENABIO

ORCID:

https://orcid.org/0000-0002-6361-5980


Formação:

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2017 - 2018

  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2014 - 2016

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 2009 - 2013

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Fisiologia) | Mestrado | 2007 - 2009

  • Universidade Federal do Estado do Rio de Janeiro

    Biomedicina | Graduação | 2003 - 2007
Laboratórios:
Nuvens de Palavras:
Artigos:

(97.83% artigos com DOI)

Titulo DOI Ano
Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling 10.3390/ijms25042392 2024
Advanced cell and gene therapies in cardiology 10.1016/j.ebiom.2024.105125 2024
Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol 10.1371/journal.pone.0300918 2024
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options 10.3390/ijms25116063 2024
Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1 10.1038/s41598-023-35944-5 2023
National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System 10.36660/abchf.20230011 2023
Early Effects of Extracellular Vesicles Secreted by Adipose Tissue Mesenchymal Cells in Renal Ischemia Followed by Reperfusion: Mechanisms Rely on a Decrease in Mitochondrial Anion Superoxide Production 10.3390/ijms23062906 2022
Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors 10.3389/fphys.2022.1077069 2022
Modelling premature cardiac aging with induced pluripotent stem cells from a hutchinson-gilford Progeria Syndrome patient 10.3389/fphys.2022.1007418 2022
Anthracycline-induced cardiotoxicity and cell senescence: new therapeutic option? 10.1007/s00018-022-04605-7 2022
Cell-Based Therapies for Heart Failure 10.3389 / fphar.2021.641116 2021
Stem cell therapies in cardiac diseases: Current status and future possibilities 10.4252/wjsc.v13.i9.1231 2021
Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice 10.3389/fphar.2021.725084 2021
Chromosomal aberrations after induced pluripotent stem cells reprogramming 10.1590/1678-4685-gmb-2020-0147 2021
Extracellular Vesicles Derived from Induced Pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model 10.3390/cells9020453 2020
Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy 10.3390/cells9071629 2020
Human Menstrual Blood-Derived Mesenchymal Cells Improve Mouse Embryonic Development 10.1089/ten.tea.2020.0034 2020
Intrinsic Angiogenic Potential and Migration Capacity of Human Mesenchymal Stromal Cells Derived from Menstrual Blood and Bone Marrow 10.3390/ijms21249563 2020
Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects 10.1016/j.scr.2019.101448 2019
Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists 10.1155/2019/7692973 2019
Proteomics in the World of Induced Pluripotent Stem Cells 10.3390/cells8070703 2019
Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient 10.1016/j.scr.2019.101490 2019
Integrin alpha-5 subunit is critical for the early stages of human pluripotent stem cell cardiac differentiation 10.1038/s41598-019-54352-2 2019
R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome 10.1038/s41598-019-55837-w 2019
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy 10.1186/s13287-018-0788-2 2018
Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives 10.1016/j.scr.2018.07.016 2018
Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure 10.1186/s13287-017-0481-x 2017
Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells 10.3892/etm.2017.4195 2017
Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials 10.5935/abc.20170176 2017
Safety of Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cell Intraspinal Transplantation in Dogs with Chronic Spinal Cord Injury 10.1155/2017/3053759 2017
Patient-derived osteosarcoma cells are resistant to methotrexate 10.1371/journal.pone.0184891 2017
Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers 10.1074/jbc.M117.807180 2017
Dual Contribution of Mesenchymal Stem Cells Employed for Tissue Engineering of Peripheral Nerves: Trophic Activity and Differentiation into Connective-Tissue Cells 10.1007/s12015-017-9786-5 2017
Sustained IGF-1 Secretion by Adipose-Derived Stem Cells Improves Infarcted Heart Function 10.3727/096368915X690215 2016
Generation of human iPS cell line ihFib3.2 from dermal fibroblasts 10.1016/j.scr.2015.09.001 2015
Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis 10.1186/s12890-015-0061-8 2015
Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stress 10.1111/jcmm.12226 2014
Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway 10.1186/scrt490 2014
Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients 10.2217/rme.13.2 2013
Isolamento, cultivo e caracterização de células derivadas de cardioesferas de camundongos CD1 2013
Adipose-Derived Stromal Cell Therapy Improves Cardiac Function After Coronary Occlusion in Rats 10.3727/096368912X636858 2012
Adipose-Derived Stem-Cell Treatment of Skeletal Muscle Injury 10.2106/jbjs.k.00351 2012
Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke 10.2217/rme.10.97 2011
Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study 10.1111/j.1478-3231.2010.02424.x 2011
Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection 10.1016/j.expneurol.2009.10.010 2010
Granulocyte-colony Stimulating Factor Treatment of Chronic Myocardial Infarction 10.1007/s10557-010-6215-2 2010
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
INVESTIGAÇÃO DA CARDIOTOXICIDADE INDUZIDA POR ANTRACICLINAS E DOS MECANISMOS DE CARDIOPROTEÇÃO DO DEXRAZOXANO ATRAVÉS DA TÉCNICA DE COMETA EM MODELO DE IPS 2024
Eritropoiese ?in vitro?: desenvolvimento de protocolo de diferenciação eritrocitária a partir de células de pluripotência induzid 2024
CARACTERIZAÇÃO DAS CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD QUE TIVERAM MUTAÇÃO CORRIGIDA UTILIZANDO EDITOR DE BASE DE ADENINA 2024
RENOMICA: A ENFERMAGEM EM UM ACOMPANHAMENTO GENÉTICO DE CARDIOMIOPATIA DILATADA 2024
USO DE CARDIOMIÓCITOS DERIVADOS DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA DE PACIENTE COM CARDIOMIOPATIA PRKAG2 PARA ANÁLISE DA EXPRESSÃO RELATIVA DE GENES ASSOCIADOS À AMPK 2024
GENERATION OF THREE ISOGENIC INDUCED PLURIPOTENT STEM CELL LINES DERIVED FROM PATIENTS WITH HUTCHINSON-GILFORD PROGERIA SYNDROME USING ADENINE BASE EDITING 2023
SCN5A-H558R polymorphism has a synergistic contribution for a long QT syndrome phenotype 2023
CARACTERIZAÇÃO FENOTÍPICA E GENOTÍPICA DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA DE PACIENTE PORTADORA DE VARIANTE NO GENE PRKAG2 2022
MODULAÇÃO DE PROPRIEDADES ELETROFISIOLÓGICAS CARDIOMIÓCITOS HUMANOS DERIVADOS DE CÉLULAS DE PLURIPOTÊNCIA INDUZIDA- IPS PELO TRATAMENTO COM SORO DE PACIENTES CHAGÁSICOS CRÔNICOS 2022
MEDICINA DE PRECISÃO: EDITANDO GENOMAS PARA FINS DIAGNÓSTICOS DE ARRITMIAS CARDÍACAS 2022
CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD COMO UMA FERRAMENTA PARA A OBTENÇÃO DE CARDIOMIÓCITOS 2022
CARACTERIZAÇÃO DAS CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA GERADAS A PARTIR DE PACIENTE COM SÍNDROME DE HUTCHINSON-GILFORD 2022
ESTABELECIMENTO DE MODELO DE CARDIOMIOPATIA INDUZIDA POR DOXORRUBICINA EM CAMUNDONGOS C57BL/6J 2022
MIMETIZANDO A CARDIOTOXICIDADE INDUZIDA POR ANTRACICLINAS UTILIZANDO CARDIOMIÓCITOS DERIVADOS DE CÉLULAS-TRONCO DE PLURIPOTÊNCIA INDUZIDA (IPSC) OBTIDAS DE PACIENTES TRATADOS COM ANTRACICLINAS 2022
INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES FROM A PATIENT CARRYING AN UNPRECEDENTED VARIANT IN THE PRKAG2 GENE SHOW GLYCOGEN STORAGE AND ARE PROMISING TOOLS FOR THE IN VITRO STUDY OF THE METABOLIC CARDIOMYOPATHY 2022
GERAÇÃO DE CÉLULAS-TRONCO HUMANAS DE PLURIPOTÊNCIA INDUZIDA PARA O ESTUDO DA CARDIOMIOPATIA PRKAG2: UMA ABORDAGEM PARA A MODELAGEM IN VITRO DA SÍNDROME 2022
CARDIAC DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS DERIVED FROM PATIENTS WITH HUTCHINSON-GILFORD PROGERIA SYNDROME 2021
REVEALING HEART REGENERATION BY ESTABLISHMENT OF IN VIVO MODELS OF CARDIAC INJURY 2021
OBTAINING IN VITRO HUMAN-INDUCED PLURIPOTENT STEM CELLS-DERIVED CARDIOMYOCYTES: AN ALTERNATIVE TO PERSONALIZED MEDICINE IN CARDIO-ONCOLOGY 2021
STRATEGIES FOR HEPATOCYTE DIFFERENTIATION DERIVED FROM INDUCED PLURIPOTENT STEM CELLS USING SPHEROIDS 2021
26 DEVELOPMENT OF AN IN VITRO STUDY MODEL OF PRKAG2 CARDIOMYOPATHY USING HUMAN INDUCED PLURIPOTENT STEM CELLS 2021
TRANSCRIPTOME ANALYSIS OF HEPATOCYTES DERIVED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS 2021
EFFECTS OF CHAGASIC PATIENT'S SERA ON HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES 2021
EFFECTS OF DOXORUBICIN ON HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES OBTAINED FROM PATIENTS SENSITIVE AND RESISTANT TO ANTHRACYCLINE-INDUCED CARDIOTOXICITY 2021
30 EARLY EFFECTS OF EXTRACELLULAR VESICLES SECRETED BY ADIPOSE TISSUE MESENCHYMAL CELLS IN RENAL ISCHEMIA FOLLOWED BY REPERFUSION: MECHANISMS RELY IN THE RESTORATION OF THE REDOX TISSULAR ENVIRONMENT 2021
MODELING LONG QT SYNDROME IN IPS-DERIVED CARDIOMYOCYTES FROM A PATIENT HARBORING THE KCNQ1- I588T MUTATION 2021
Effects of Chagasic patients' sera on human cardiomyocytes derived from iPS 2021
Infecção de megacarioblastos humanos em diferenciação pelo vírus da febre amarela 2018
As células-tronco podem ser utilizadas como tratamento para cardiomiopatia induzida por doxorrubicina? 2018
Avanços na medicina personalizada na SqTL1 utilizando cardiomiócitos paciente-específicos 2018
Investigating Long QT Syndrome type 1 by in vitro generation of human patient-specific cardiomyocytes 2018
Challenges to modeling JLNS using patient-specific cardiomyocytes derived from induced pluripotent stem cells 2018
Patient-specific iPSC-derived cardiomyocytes as a model of type 1 Long QT Syndrome 2018
Action potential variability in human pluripotent stem-derived cardiomyocytes obtained from healthy donors 2018
ABTCEL -X Congress 2018
Modelling a novel KCNQ1 gene variant associated with Type I Long-QT Syndrome 2017
Uma nova alternativa para medicina personalizada: geração in vitro de cardiomiócitos paciente-específicos a partir de células-tronco de pluripotência induzida 2017
Modeling premature cardiac aging by induced pluripotent stem cell from a patient with Hutchinson-Gilford progeria syndrome (HGPS) 2017
Genomic Integrity in Induced Pluripotent Stem Cells 2017
Embryonic stem cell-derived cardiomyocytes improve cardiac function in a mouse model of doxorubicin-induced cardiomyopathy 2017
Investigação dos Mecanismos Moleculares da Síndrome do QT Longo do tipo 2 utilizando cardiomiócitos derivados de iPSC 2017
Medicina Personalizada na SQTL1: geração in vitro de cardiomiócitos paciente-específicos 2017
Bone marrow mesenchymal stem cell therapy in a canine model of chagasic cardiomyopathy 2017
Investigating Molecular mechanisms of Type 2 Long QT Syndrome with iPSC-derived cardiomyocytes 2017
Modelling premature cardiac aging by induced pluripotent stem cell from a patient with hutchinson-Gliford progeria syndrome 2017
Avaliação do potencial terapêutico das células estromais mesenquimais derivadas de medula óssea em modelo de cardiomiopatia chagásica canina 2017
Investigação das possíveis alterações causadas pela infecção pelo vírus da febre amarela na diferenciação de megacarioblastos humanos 2017
Does yellow fever virus induce alterations in differentiation process of megakaryoblasts? 2017
Investigation of possible alterations in megakaryoblasts differentiation caused by the infection of yellow fever virus 2017
Infection of Megacayoblasts under differentiation by yellow fever virus 2017
Avaliação da Instabilidade Genética de Células-tronco Pluripotentes Induzidas 2016
Modelling Type 2 long QT syndrome using iPSC-derived cardiomyocytes 2016
Morphologic and Functional Evaluation of Myocardial Infarction in Wistar Rats: a Comparative Study Between Females and Males 2015
Improvement of Cardiac Function by Embryonic Stem Cell Derived Cardiomyocytes in Doxorubicin Induced Cardiomyopathy Model 2015
Embryonic stem cell-derived cardiomyocytes increase viable myocardium but do not improve function in a mouse model of chagasic cardiomyopathy 2015
Avaliação morfo-funcional do infarto do miocárdio em ratos Wistar: um estudo comparativo entre fêmeas e machos 2015
Generation and Cardiac Differentiation of Feedere Free iPSC 2014
Cardiomyocytes Derived from Mouse Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy 2014
Characterization of Cardiac Progenitor Cells and Evaluation of their Therapeutical Potential in a Murine Model of Healed Myocardial Infarction 2014
Uma nova perspectiva para o estudo da Síndrome do QT longo: geração de células-tronco pluripotentes induzidas pacientes-específicas 2014
Human cardiac stem cell therapy in immunossuppressed rats with myocardial infarction 2012
Temporal expression of c-kit in the heart: difficulties and chalenges in cell therapy 2012
Isolation, culture and characterization of cardiospheres-derived cells from CD1 mice 2012
Reprogramming of oxidative stress responses in human induced pluripotent stem cells derived from menstrual blood 2012
Direct reprogramming of fibroblasts into cardiomyocytes by ectopic gene expression of GATA-4, MEF2c and TBX5 2012
Reprogramming to a Pluripotent State Modifies Menstrual Blood-Derived Mesenchymal Stem Cell Resistance to Oxidative Stress 2012
MESENCHYMAL STEM CELLS FROM MENSTRUAL BLOOD ARE MORE RESISTANT TO OXIDATIVE STRESS THAN PLURIPOTENT STEM CELLS. 2012
Development of chagasic cardiomyopathy model in chimeric mice 2011
Cardiomyogenic potential of cardiosphere-derived cells 2011
Isolation of clonogenic c-kit positive cells from human heart 2011
Mesenchymal cells obtained from human amniotic fluid: characterization and evaluating their potential to differentiate into cardiomyocytes 2011
Cardiac differentiation of human umbilical cord-deived stromal cells 2011
Eletrophysiological characterization of umbilical cord-derived stromal cells 2011
Transplantation of human placenta-derived mesenchymal stromal cells improves cardiac performance of immunocompetent mice submitted to myocardial infarction 2011
Human menstrual blood as a source of stem cells resistant to oxidative stress 2011
Menstrual blood-derived stem cells are not impaired by oral-contraceptives 2011
Characterization of freshly isolated non-myocyte cell populations from mouse hearts 2011
Isolation and characterization of cardiosphere derived cell from human heart 2011
Bone marrow transplantation: what is the best delivery site for engrafment in mice? 2011
Adipose-Derived Stromal Cell Therapy Stabilizes Cardiac Function and Improves Border Zone Remodeling After Coronary Occlusion in Rats 2011
Characterization of cells from human amniotic fluid and evaluating their potential to differentiate into cardiomyocytes 2011
HUMAN MENSTRUAL BLOOD-DERIVED MESENCHYMAL CELLS: CHARACTERIZATION AND EVIDENCE FOR ENHANCED RESISTANCE AGAINST OXIDATIVE STRESS 2011
PRELIMINARY STUDY OF MOUSE EMBRYONIC STEM CELL TRANSPLANTATION IN MICE EXPERIMENTALLY INFECTED WITH T. cruzi. 2011
TRANSPLANTATION AND BIODISTRIBUTION OF HUMAN PLACENTA-DERIVED MESENCHYMAL STROMAL CELLS IN IMMUNOCOMPETENT MICE SUBMITTED TO MYOCARDIAL INFARCTION. 2011
Transplantation of placenta-derived mesenchymal stem cells in immunocompetent mice submitted to myocardial infarction 2011
The development of a chagasic cardiomyopathy model in chimeric mice 2011
Cardiomyocyte differentiation of human amniotic fluid-derived mesenchymal stem cells 2010
Human Menstrual Blood derived mesenchymal cells are an alternative feeder-layer for human embryonic stem cells 2010
Effects of Trypanosoma cruzi infection in human cardiac progenitor cells 2010
A comparative study of human fetal extra-embryonic mesenchymal stem cells 2010
Transplantation of placenta-derived mesenchymal stem cells in immunocompetent mice submitted to myocardial infarction 2010
Human hair follicle feeder-layers support undifferentiated growth of human embryonic stem cells 2010
Biodistribuição de células mononucleares de medula óssea marcadas com 99mTecnécio após injeção intra-arterial ou intravenosa em pacientes com AVC isquêmico crônico 2010
Cardiosphere-derived cells have a mesenchymal phenotype and express contractile molecules when co-cultured with neonatal cardiomyocytes 2010
Cardiosphere-derived cells: new perspective in the cardiac cell therapy 2010
Stem Cells amniotic fluid-derived might be considered an alternative source of stem cells for cardiac cell therapy 2010
Immunophenotyping and differentiation of adherent fraction of cells isolated from human cardiac biopsies 2010
Isolation and characterization of human umbilical cord stromal cells 2010
Human Menstrual Blood and hair follicle derived mesenchymal cells are alternative feeder-layer for mouse and human embryonic stem cells 2010
Mouse Embryonic Stem Cell Transplantation in Mice Experimentally Infected with T. cruzi : Preliminary Results. 2010
Infection with Trypanosoma cruzi does not promote apoptosis in human cardiac progenitor cells 2010
Placenta-derived mesenchymal stromal cells in myocardial infarction therapy: preliminary results. 2010
Characterization of human menstrual blood-derived mesenchymal cells and detection by bioluminescence imaging in vivo. 2010
Avaliação da distribuição de células mononucleares de medula óssea marcadas com 99mTecnécio após injeção intra-arterial ou intravenosa em pacientes com AVC isquêmico crônico 2010
Investigação do potencial de diferenciação in vitro das células-tronco derivadas do líquido amniótico humano em cardiomiócitos. 2010
THE AMNIOTIC FLUID AS A SOURCE OF CELLS FOR CELL THERAPY 2010
A comparative study of human fetal extra-embryonic mesenchymal stem cells 2010
Morpho-functional characterization of bone marrow cells isolated from patients with chronic diseases 2009
Isolation and characterization of human umbilical cord stromal cells 2009
Expression of cardiac-specific genes by multipotent human amniotic fluid-derived stem cells: preliminary results 2009
Analysis of cell populations obtained from C57/BL6-Tg pCX (a-act)EGFP Transgenic mice adipose tissue 2009
Isolamento, caracterização e diferenciação das células humanas derivadas do sangue menstrual 2009
Células derivadas do líquido amniótico humano: nova perspectiva de célula-tronco 2009
Characterization of cardiac progenitor cells from human adult myocardium 2009
Characterization of placenta derived stem cells 2009
Isolation and characterization of bone marrow-derived mesenchymal stem cells from alpha actin cardiac-EGFP transgenic mice 2009
Isolation, expansion and characterization of cardiac stem cells from adult murine heart 2009
Menstrual blood-derived cells: new progenitor cell source for stem cell-based therapies 2009
Morphologic and Phenotypic Characterization of Cell Populations Obtained from Outbred Wistar Rat Adipose Tissue Derived Cells 2009
In vitro study of human bone marrow mononuclear and mesenchymal cells derived from stroke patients 2008
Term placenta as a new source of multipotent mesenchymal stromal cells 2008
Human amniotic fluid derived cells: new perspective stem cells 2008
Células mesenquimais derivadas da placa coriônica: um estudo sobre isolamento, caracterização e diferenciação 2008
Isolation and characterization of amniotic membrane mesenchymal cells 2008
Isolamento, caracterização, diferenciação e cultivo das células derivadas do fluido amniotico humano 2008
Células derivadas do fluido amniótico humano: uma nova fonte de célula-tronco mesenquimal? 2008
Expression of muscle markers in bone marrow mesenchymal stem cells 2007
Expression of muscle markers in bone marrow mesenchymal stem cells. 2007
Isolamento, caracterização e cultivo de células de medula óssea humana 2007
Autologous bone marrow mononuclear cell transplantationin patients with schemic stroke 2007
Publicações:
Minha Rede: